![EGFR inhibition led ROCK activation enhances desmosome assembly and cohesion in cardiomyocytes | bioRxiv EGFR inhibition led ROCK activation enhances desmosome assembly and cohesion in cardiomyocytes | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2022/06/21/2022.04.27.489705/F8.large.jpg)
EGFR inhibition led ROCK activation enhances desmosome assembly and cohesion in cardiomyocytes | bioRxiv
![EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles - ScienceDirect EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S037851732031067X-gr1.jpg)
EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles - ScienceDirect
![A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components | Science Translational Medicine A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aaz4589/asset/b5936c8d-1c15-4f74-b60c-4bf7aeb2ccb0/assets/graphic/aaz4589-f1.jpeg)
A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components | Science Translational Medicine
![Inhibition of Brain Epidermal Growth Factor Receptor Activation: A Novel Target in Neurodegenerative Diseases and Brain Injuries | Molecular Pharmacology Inhibition of Brain Epidermal Growth Factor Receptor Activation: A Novel Target in Neurodegenerative Diseases and Brain Injuries | Molecular Pharmacology](https://molpharm.aspetjournals.org/content/molpharm/98/1/13/F1.medium.gif)
Inhibition of Brain Epidermal Growth Factor Receptor Activation: A Novel Target in Neurodegenerative Diseases and Brain Injuries | Molecular Pharmacology
![Inhibiting Epidermal Growth Factor Receptor Improves Structural, Locomotor, Sensory, and Bladder Recovery from Experimental Spinal Cord Injury | Journal of Neuroscience Inhibiting Epidermal Growth Factor Receptor Improves Structural, Locomotor, Sensory, and Bladder Recovery from Experimental Spinal Cord Injury | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/27/24/6428/F4.large.jpg)
Inhibiting Epidermal Growth Factor Receptor Improves Structural, Locomotor, Sensory, and Bladder Recovery from Experimental Spinal Cord Injury | Journal of Neuroscience
![Cancers | Free Full-Text | Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression Cancers | Free Full-Text | Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression](https://www.mdpi.com/cancers/cancers-15-02970/article_deploy/html/images/cancers-15-02970-g001.png)
Cancers | Free Full-Text | Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression
![Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients | British Journal of Cancer Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6604781/MediaObjects/41416_2009_Article_BF6604781_Fig1_HTML.jpg)
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients | British Journal of Cancer
![Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality](https://www.frontiersin.org/files/Articles/564983/fonc-10-01688-HTML-r1/image_m/fonc-10-01688-g001.jpg)
Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality
Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy | Journal of Medicinal Chemistry
![Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations | Science Signaling Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations | Science Signaling](https://www.science.org/cms/10.1126/scisignal.2005786/asset/a26c7bc6-b2b0-47b4-8e3e-a09e328ec539/assets/graphic/7_ra114_f1.jpeg)
Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations | Science Signaling
![Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy | Cell Communication and Signaling | Full Text Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy | Cell Communication and Signaling | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12964-022-00960-x/MediaObjects/12964_2022_960_Fig1_HTML.png)
Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy | Cell Communication and Signaling | Full Text
![EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles - ScienceDirect EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S037851732031067X-ga1.jpg)
EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles - ScienceDirect
![Uncommon EGFR mutations in non-small-cell lung cancer: A systematic literature review of prevalence and clinical outcomes - ScienceDirect Uncommon EGFR mutations in non-small-cell lung cancer: A systematic literature review of prevalence and clinical outcomes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1877782121001971-gr1.jpg)
Uncommon EGFR mutations in non-small-cell lung cancer: A systematic literature review of prevalence and clinical outcomes - ScienceDirect
![EGFR signaling is critical for macrophage activation and function. (A)... | Download Scientific Diagram EGFR signaling is critical for macrophage activation and function. (A)... | Download Scientific Diagram](https://www.researchgate.net/publication/305786536/figure/fig6/AS:390979967307783@1470228297237/EGFR-signaling-is-critical-for-macrophage-activation-and-function-A-mRNA-levels-of-the.png)
EGFR signaling is critical for macrophage activation and function. (A)... | Download Scientific Diagram
![Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies | Oncogene Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies | Oncogene](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41388-017-0045-7/MediaObjects/41388_2017_45_Fig1_HTML.jpg)
Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies | Oncogene
![Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer | Experimental & Molecular Medicine Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer | Experimental & Molecular Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs12276-018-0202-2/MediaObjects/12276_2018_202_Fig1_HTML.png)
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer | Experimental & Molecular Medicine
![Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer | Clinical and Translational Oncology Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer | Clinical and Translational Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12094-023-03286-3/MediaObjects/12094_2023_3286_Fig1_HTML.png)
Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer | Clinical and Translational Oncology
![The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered - Gan - 2013 - The FEBS Journal - Wiley Online Library The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered - Gan - 2013 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/47f560d0-0a15-4f4f-ae0e-3e24879199aa/febs12393-fig-0002-m.jpg)
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered - Gan - 2013 - The FEBS Journal - Wiley Online Library
![IJMS | Free Full-Text | The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer IJMS | Free Full-Text | The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer](https://www.mdpi.com/ijms/ijms-23-07213/article_deploy/html/images/ijms-23-07213-g001.png)